Skip to main content

Table 2 Association of pemetrexed treatment responses with clinicopathological data from lung adenocarcinoma patients

From: Association of thymidylate synthase gene 3'-untranslated region polymorphism with sensitivity of non-small cell lung cancer to pemetrexed treatment: TS gene polymorphism and pemetrexed sensitivity in NSCLC

 

No. of patients

Efficacy

χ2

P value

CR + PR

Age (years)

 < 60

50

16

3.7

0.06

 ≥ 60

56

9

Gender

 Male

62

10

4.6

0.03

 Female

44

15

Disease stage

 IIIB

78

24

5.6

0.02

 IV

28

1

ECOG grade

 0

36

13

5.0

0.08

 1

54

10

 2

16

2

Genotype

 −6 bp/-6 bp

59

19

5.5

0.02

 −6 bp/+6 bp

47

6

Expression of TS protein

 TS(+)

67

11

5.1

0.02

 TS(−)

39

14